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Abstract
The permeability transition pore (PTP) is a channel of the inner mitochondrial membrane that appears to operate at the
crossroads of two distinct physiological pathways, i.e., the Ca2 signaling network during the life of the cell, and the effector
phase of the apoptotic cascade during Ca2-dependent cell death. Correspondingly, two open conformations of the PTP can
also be observed in isolated organelles. A low-conductance state, that allows the diffusion of small ions like Ca2, is pH-
operated, promoting spontaneous closure of the channel. A high-conductance state, that allows the unselective diffusion of
big molecules, stabilizes the channel in the open conformation, disrupting in turn the mitochondrial structure and causing the
release of proapoptotic factors. Our current results indicate that switching from low- to high-conductance state is an
irreversible process that is strictly dependent on the saturation of the internal Ca2-binding sites of the PTP. Thus, the high-
conductance state of the PTP, which was shown to play a pivotal role in the course of excitotoxic and thapsigargin-induced
cell death, might result from a Ca2-dependent conformational shift of the low-conductance state, normally participating in
the regulation of cellular Ca2 homeostasis as a pH-operated channel. These observations lead us to propose a simple
biophysical model of the transition between Ca2 signaling and Ca2-dependent apoptosis. ß 1998 Elsevier Science B.V.
All rights reserved.
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1. Introduction
For some obscure reasons, and in spite of an ex-
haustive number of clues, it took nearly 40 years
after Mitchell proposed his chemosmotic model of
oxidative phosphorylation [1] to realize that mito-
chondria are not simply cellular power plants as-
signed to ATP production. As a matter of fact, the
mitochondrial transmembrane proton gradient main-
0005-2728 / 98 / $19.00 ß 1998 Elsevier Science B.V. All rights reserved.
PII: S 0 0 0 5 - 2 7 2 8 ( 9 8 ) 0 0 1 1 9 - 4
Abbreviations: CICR, Ca2-induced Ca2 release; CsA, cyclo-
sporin A; v8, mitochondrial membrane potential ; ER, endoplas-
mic reticulum; IP3, inositol 1,4,5-trisphosphate; NMDA, N-
methyl-D-aspartate; PTP, permeability transition pore; RaM,
rapid mode of mitochondrial Ca2 uptake
* Corresponding author, at address b. Fax: +39 (49) 8276361;
E-mail : ichas@u-bordeaux2.fr
BBABIO 44663 28-7-98
Biochimica et Biophysica Acta 1366 (1998) 33^50
tained by respiration is used by the organelle as a
versatile driving force for a variety of tasks that
have little to do with ATP synthesis [2]. Among
these, two purely dissipative tasks, i.e. that do not
couple the dissipation of the proton gradient to any
kind of thermodynamic work, have recently been
proposed to play pivotal roles in the life and in the
death of the cell. Both these mitochondrial tasks cor-
respond to signal transduction processes, and as such
involve the downhill release of signaling ions and/or
molecules from the organelle. Both these signaling
events have been proposed to depend on a Ca2-ac-
tivated channel of the inner mitochondrial mem-
brane ^ the permeability transition pore (PTP) ^
characterized by Hunter and Haworth in the 1970s
[3^8] (see [9] for a comprehensive review), and the
opening of which results in the dissipation of several
transmembrane electrochemical gradients. Indeed,
while evidence indicates that the PTP is a channel
that mitochondria operate to release Ca2 and par-
ticipate in the intracellular Ca2 signaling network
during the normal life of the cell [10^14], several
reports concerning neuronal excitotoxicity [15^19]
and thapsigargin-induced apoptosis [20] give also
credit to the idea that the Ca2-dependent operation
of the PTP is a key event committing the cell to an
apoptotic fate, probably by causing swelling of the
mitochondrial matrix, rupture of the outer mem-
brane, and release of proapoptotic factors contained
in the former intermembrane space [21^23]. We dis-
cuss here this dual function, and analyze it in terms
of variability of PTP open conformation [7,9,14,24^
26].
2. Low-conductance state of the PTP and Ca2+
signaling
The idea that the PTP might be relevant to cellular
Ca2 homeostasis as a mitochondrial Ca2-activated
Ca2 release channel has been hypothesized for a
long time, mainly on the basis of phenomenologic
and thermodynamic considerations [3,7,27]. The ¢rst
experimental report giving credit to this view came
from the group of Halestrap and concerned the reg-
ulation of mitochondrial volume in hepatocytes chal-
lenged with the Ca2-mobilizing hormone vasopres-
sin [10]. In their study, the authors found that after
vasopressin challenge, mitochondria were undergoing
in situ a swelling process that could be partially pre-
vented by cyclosporin A (CsA). Since CsA is a po-
tent inhibitor of the PTP [28^31], these results could
be interpreted in terms of PTP opening triggered by
Ca2 signaling events [10]. A few years later, a key
report concerning Ca2 homeostasis in intact cardi-
omyocytes at rest provided further evidence of PTP
£ickering in situ [11]. In this report, Altschuld and
colleagues showed that a signi¢cant amount of the
total cellular Ca2 transits through mitochondria,
entering the organelle in a ruthenium red-sensitive
manner, i.e., via the Ca2 uniporter, and leaving it
through a CsA-sensitive pathway, i.e., the PTP. Us-
ing the same type of approach in hepatocytes, the
group of Orrenius reported the same year observa-
tions compatible with the latter view [12]. However,
with regard to the models of the PTP that were cur-
rent at that time, few people in the ¢eld were open to
the idea that a channel apparently solely capable of
causing a global and nearly irremediable disruption
of mitochondrial homeostasis in vitro could repre-
sent a structure of any relevance to the normal phys-
iology of the cell.
2.1. Low-conductance state of the PTP and
mitochondrial Ca 2+-induced Ca 2+
release (CICR)
Yet, it became rapidly evident that the PTP is
endowed with the characteristics of a fully reversible
CICR channel capable of transient opening
[13,14,32,33], preserving other mitochondrial func-
tions such as volume homeostasis [14]. Signs of
such behavior had been observed in vitro for years
by the group of Evtodienko (reviewed in [32^34]),
but were only recently attributed to the operation
of a speci¢c narrow conformation of the pore [14].
It is important to note that as early as 1979, Ha-
worth and Hunter detected and discussed the process
of PTP £ickering [6], as well as the existence of a
PTP subconductance state [7] (see also Section 6).
In intact organelles, we observed that mitochon-
drial CICR is promoted by the latter type of PTP
conformation [14] (i) with an apparent molecular
cuto¡ 6 300 Da, i.e. 5 times smaller than the high-
conductance state [6], and permeable to small ions
like protons, Ca2, or K, (ii) that does not cause
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mitochondrial swelling, (iii) and principally operated
by matrix pH [14,35] (see also Table 1). Other au-
thors have recently proposed an even narrower con-
formation of the PTP that would be selective for
protons [25,26], and that could promote mitochon-
drial CICR as well by behaving as a pure depolariz-
ing channel (see explanation below).
In electrophysiological studies, several subconduc-
tance levels of the PTP have been described by Szabo'
and Zoratti [9], and by the group of Kinnally [24].
One of these, corresponding to a half-conductance
state of approx. 500 pS, promotes pore £ickering,
at variance from the full-conductance state that
most often develops from the 500 pS state and sub-
sequently blocks the pore in the open conformation
at 1200 pS [9]. It thus seems likely that the £ickering
500 pS state of the PTP observed in patch clamp
studies [9,24] corresponds to the low-conductance
conformation of the PTP evidenced in intact organ-
elles [7,14].
The proposed mechanism by which the PTP pro-
motes mitochondrial CICR is based on the observa-
tion that matrix pH seems to be the major regulator
of the low-conductance conformation [14,35] (see
also Section 4), and can be described as follows: (i)
a Ca2 signal reaches the organelle, (ii) Ca2 enters
the mitochondrion due to v8 which is negative in-
side, (iii) charge compensation by the respiratory
chain raises matrix pH, (iv) high matrix pH triggers
PTP opening, (v) PTP opening collapses the proton
gradient causing decline of v8, outward redistribu-
tion of Ca2, and matrix acidi¢cation, (vi) matrix
acidi¢cation closes the PTP, (vii) respiratory chain
Table 1
Modulators of the two conductance states of the PTP
Channel modulator Low-conductance PTP High-conductance PTP
E¡ect Ref. E¡ect Ref.
Ca2 u [13,14,32,33] u [3^8]
Sr2 v [34] ;[b] t [3,5^8]
Mg2 s [a] s [3,5^8]
H s [14] ;[b] s [6,44,65]
ADP s [14,32,33] s [3,5^8]
Pi t [a] v [3]
CsA s [13,14,32,33] s [28^31]
SDZ-PSC833 t [13] a [a]
Up arrow, activator; down arrow, inhibitor; circle, no e¡ect; [a] Ichas et al. unpublished; [b] present manuscript; single arrows, com-
mon modulators; double arrows, modulators having di¡erent e¡ects on the two conductance states. The list is limited to the modula-
tors that have been investigated on both conductance states.
Fig. 1. Schematic model of the transmembrane ion £uxes asso-
ciated with triggering, opening, and closure of the PTP in its
low-conductance conformation. After [13,14,35]. In the car-
toons: left, Ca2 uniporter (white) ; central, PTP (black); right,
respiratory chain (grey). Phase 1: the respiratory chain main-
tains the proton gradient that is responsible for membrane po-
larization (v8). Ca2 enters mitochondria due to v8 through
the uniporter, while the respiratory chain electrically compen-
sates the resulting in£ux of positive charges by extruding more
protons. As a result, matrix pH increases. Phase 2: high matrix
pH triggers PTP opening. The latter provides an inward path-
way for protons that shunts the activity of the respiratory
chain, and collapses v8. As a result, Ca2 undergoes an out-
ward redistribution, and matrix pH decreases. Note that Ca2
e¥ux takes place through both the uniporter and the PTP.
Phase 3: low matrix pH closes the PTP. PTP closure stops pro-
ton in£ow, and the respiratory chain restores the proton gra-
dient and corresponding v8. Ca2 is reaccumulated due to re-
stored v8, and matrix pH increases again.
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rebuilds the proton gradient, thus restoring v8, (vii)
restored v8 drives Ca2 re-uptake (Fig. 1) [14,35]. It
should be noted that phase (vii) is equivalent to
phase (i), and thus, that the whole cycle might repeat
inde¢nitely, leading to pore £ickering and oscillatory
ion £uxes [32,35] (Fig. 2). Regarding conformational
considerations, it should also be noted that a proton-
selective conformation of the PTP [25,26] could ac-
count for phase (v) as well. Indeed, the Ca2 uni-
porter present in the inner mitochondrial membrane
is a fast and symmetric Ca2 channel that can trans-
port Ca2 in both directions [27]. Thus, transient
collapse of v8 by a proton-selective PTP would
also result in the outward redistribution of Ca2,
due to reverse £ow through the Ca2 uniporter.
The dependence of the low-conductance PTP con-
formation on matrix pH ^ rather than on matrix
Ca2 ^ is a notable characteristic. Owing to such
control, triggering of mitochondrial CICR does not
depend on the absolute amount of Ca2 taken up by
mitochondria, but rather on the rate at which Ca2 is
provided to the organelles [13,14,34,35]. Indeed, for
the same amount of Ca2 provided, mitochondria
can behave either as Ca2 storage organelles when
Ca2 is delivered slowly, or undergo CICR when
Ca2 is delivered at a fast rate (see also Fig. 8).
Thus, triggering of the narrow conformation of
the PTP by matrix pH rather than by Ca2 itself
allows the organelles to integrate and process
Ca2 inputs on a temporal/frequency-dependent ba-
sis [13,14,34,35]. We will come back to this feature in
Section 4 and Section 5 regarding cell death.
2.2. PTP and Ca 2+ signaling: theoretical sketch
The features of the low-conductance state of the
PTP, and of its function of CICR channel deter-
mined in vitro, can be used to determine whether
its participation in the intracellular Ca2 network is
feasible in situ, at least on theoretical grounds. The
in vitro experiments tell us that signi¢cant amounts
of Ca2 need to be translocated inside mitochondria
(30^50 nmol mg31 [13,14,32^34]) at a fast rate (s 90
nmol mg31Umin31 [14]), in order to raise matrix pH
high enough to trigger mitochondrial CICR. If we
assume that theses quantitative values are directly
relevant to the in situ context, we can predict that
only a subset of the cellular mitochondrial popula-
tion is susceptible to operate the PTP as a CICR
channel.
If we consider mitochondria sensing the average
height of a standard cytosolic Ca2 transient, i.e.
with a peak amplitude of 500^1500 nM and lasting
for 5 s, we can deduce from the kinetics of the Ca2
uniporter [27] that a maximum of 0.5^4 nmol mg31
can be transferred through the uniporter, at a rate
varying between 10 and 80 nmol mg31Umin31 [27].
However, operation of the rapid uptake mode
(RaM) must also be taken into account [36]. Consid-
ering that RaM-mediated Ca2 uptake occurs during
the initial 100 ms of the peak, at a rate two orders of
magnitude higher than uniport-mediated uptake
(T.E. Gunter, personal communication; see also
[36]), then an additional amount of 1.7^13 nmol
mg31 must be considered. In this case, we come up
with a total Ca2 transfer of 2.3^17 nmol mg31, at a
mean rate varying between 46 and 340 nmol
mg31Umin31. While the upper value exceeds ^ in
terms of rate ^ the threshold of mitochondrial
CICR, the amounts translocated do not meet the in
vitro requirements.
Let us now consider mitochondria tightly associ-
ated with the intracellular Ca2 release channels of
the endoplasmic reticulum (ER) [37]. When Ca2
transients are generated, these particular mitochon-
dria sense local Ca2 ‘hot spots’ and take up the
cation at an extremely fast rate due to the high local
Ca2 concentration (s 20 WM according to recent
Fig. 2. Heuristic model of mitochondrial CICR. After [14,35].
For details see text and Fig. 1.
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direct measurements; R. Rizzuto, personal commu-
nication). This results in free matrix [Ca2] transients
peaking at 5^10 WM above the baseline [37,38]. Since
the bound/free Ca2 ratio in mitochondria in vivo is
approx. 6000 [39], the amplitude of the free matrix
[Ca2] transients observed at the level of these par-
ticular mitochondria re£ects a quantity of Ca2
translocated of 30^60 nmol mg31. Moreover, this
transfer occurs within approx. 5 s [37,38], giving a
rate between 600 and 1200 nmol mg31Umin31.
These values, deduced from matrix parameters, are
similar to the ones that can be calculated from the
kinetics of the uniporter. Indeed, for extramitochon-
drial Ca2 concentrations exceeding 20 WM, the uni-
porter transports Ca2 at a rate that varies between
600 and 1200 nmol mg31Umin31 [27], which, in 5 s,
results in the transfer of 50^100 nmol mg31. Thus,
whatever the mode of calculation, these values all
exceed the requirements of mitochondrial CICR op-
eration observed in vitro.
Thus, this analysis suggests that mitochondrial
CICR is most likely (i) to occur speci¢cally at the
level of the mitochondria tightly associated with the
Ca2 release channels of the ER (like the IP3 recep-
tor), and (ii) to be triggered immediately after, and
each time Ca2 is released from the ER (Fig. 3).
2.3. PTP and Ca 2+ signaling: experimental results
Experimentally, three studies con¢rm the idea that
PTP operation occurs in situ, and is dependent on
such a Ca2 cross-talk between the ER and the
neighboring mitochondria. Davidson and Halestrap
reported as early as 1990 that in hepatocytes chal-
lenged with vasopressin ^ which mobilizes Ca2 from
the ER ^ mitochondria undergo a swelling process in
situ that can be partially inhibited by CsA [10]. This
result can be interpreted in terms of PTP opening
triggered by the transfer of Ca2 from the ER to
mitochondria. Four years later, while we were exam-
ining the di¡erential sensitivity of mitochondrial
CICR to two distinct CsA derivatives in vitro, we
observed in parallel experiments that the amplitude
of IP3-dependent cytosolic Ca2 signals triggered in
intact Ehrlich carcinoma cells exhibited a similar dif-
ferential sensitivity to the two CsA derivatives under
study [13]. In other words, the cyclosporin that was
the more potent at inhibiting mitochondrial CICR,
appeared to be also the more e⁄cient at decreasing
the size of the cytosolic Ca2 transients in intact
cells. In addition, the inhibiting e¡ects of CsA on
the cytosolic Ca2 signals could be mimicked by pre-
treating the cells with antimycin A that collapses v8,
and prevents all mitochondrial Ca2 £uxes. We thus
proposed that mitochondrial CICR, i.e., transient
PTP operation, is triggered shortly after Ca2 is re-
leased from the ER, and contributes to a signi¢cant
part of the ¢nal cytosolic Ca2 signal [13]. By mon-
itoring both intramitochondrial Ca2 and v8 during
the early phase of IP3-dependent Ca2 signals, we
later obtained results con¢rming that the PTP is a
Ca2 release channel relevant to the regulation of
cellular Ca2 homeostasis. We found that shortly
after Ca2 is released from the ER by IP3, mitochon-
dria undergo a transient membrane depolarization,
as well as a transient decrease in their Ca2 contents,
Fig. 3. Schematic model of mitochondrial CICR participation in the Ca2 signaling network. After [13,14,37]. The reticular structure
represents the ER, and the organelles with cristae are mitochondria. The right-hand mitochondrion is located in a Ca2 microdomain,
close to an IP3 receptor of the ER (empty square). (A) During the initial mobilization of Ca2 from the ER, the right-hand mito-
chondrion takes up Ca2 via the uniporter (closed circle), while the left-hand mitochondrion is too far away from the Ca2 release
site to do so. (B) Mitochondrial CICR occurs at the level of the right-hand mitochondrion due to PTP opening (empty circle), which
ampli¢es the cytosolic signal, and the left-hand mitochondrion starts only now accumulating Ca2. (C) All the organelles accumulate
Ca2 (uniporter: closed circle; Ca2-ATPase: closed square). The transmembrane arrows indicate the direction of the net Ca2 £uxes.
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that can both be inhibited by CsA. We again ob-
served that the release of Ca2 from mitochondria
that occurs during this phase ampli¢es the cytosolic
Ca2 signal, further indicating that the PTP is a
channel that mitochondria operate transiently to
take an active part in Ca2 signaling processes [14].
Two other studies, published in 1992, also evi-
denced that PTP £ickering is a process contributing
to the regulation of cellular Ca2 homeostasis
[11,12]. However, in these reports, the possible de-
pendence of PTP opening on an initial release of
Ca2 from the ER was not investigated. Altschuld
and colleagues [11] reported that the net uptake of
45Ca2 by isolated cardiomyocytes at rest is dramat-
ically increased when the cells are incubated in the
presence of CsA, and that the e¡ects of CsA can be
fully reversed by the introduction of ruthenium red
in the extracellular medium (ruthenium red blocks
mitochondrial Ca2 uptake [27]). The authors logi-
cally concluded that in the presence of CsA mito-
chondria are continuously accumulating Ca2 with-
out possible release through the PTP, and that such
mitochondrial overaccumulation is prevented when
the in£ux pathway ^ the mitochondrial Ca2 uni-
porter ^ is also blocked with ruthenium red [11].
The group of Orrenius observed in the same year
that in the presence of CsA the mitochondria of in-
tact hepatocytes become progressively overloaded
with Ca2 in situ [12], again suggesting that the
PTP is a physiological pathway for mitochondrial
Ca2 e¥ux.
Finally, a recent communication by Di Lisa and
colleagues, based on a di¡erent and original method,
gives further credit to the idea that the PTP is a
channel operated almost constantly by mitochondria
in situ (Di Lisa, personal communication, and [40]).
However, in this work, the correlation of PTP func-
tion with Ca2 homeostasis was not investigated. In
their study, the authors loaded hepatoma cells with
calcein-AM, and subsequently quenched the cyto-
solic signal by perfusing the cells with cobalt. After
cobalt washout, mitochondria (which did not take up
cobalt during the perfusion) could be imaged as £u-
orescent calcein-containing organelles over a dark
cellular background. By recording the time course
of calcein £uorescence at the level of individual mi-
tochondria, the authors could evidence a spontane-
ous and constant £uorescence decrease that could be
abolished by CsA. Since mitochondria maintain a
high mean v8 value under these conditions, the re-
sults are indicative of constant £ickering of the PTP
(i) under a conformation that does not impair mito-
chondrial functions, and (ii) allowing gradual calcein
release and/or cobalt in£ux.
2.4. Summary
The PTP can adopt di¡erent open conformations.
Under its low-conductance conformation, the PTP (i)
does not impair mitochondrial functions, like volume
homeostasis, and can £icker in vitro and in situ; (ii)
is operated by the changes in matrix pH accompany-
ing mitochondrial Ca2 uptake; and (iii) is involved
as a mitochondrial Ca2 release channel in the reg-
ulation of cellular Ca2 homeostasis.
3. High-conductance state of the PTP and cell death
Historically, the high-conductance state of the PTP
was the ¢rst to be characterized by Hunter and Ha-
worth in isolated organelles [3^8]. The process of
permeability transition was described as a pathway
for mitochondrial Ca2 e¥ux [7], dependent on the
opening of a Ca2-activated hydrophilic channel of
the inner membrane [6,8], later characterized electro-
physiologically and termed ‘megachannel’ by Sza-
bo' and Zoratti [9,41,43,44,46,47], or ‘multiple con-
ductance channel’ by the group of Kinnally [24,42,
45,48,49]. In its high-conductance state, the PTP ren-
ders the inner mitochondrial membrane unselectively
permeable to solutes of molecular mass 6 1500 Da
[6] and remains open, unless Ca2 is chelated by
addition of EGTA [3,6]. Since mitochondria with
an open high-conductance pore can no longer main-
tain a proton gradient, and thus no longer sustain
oxidative phosphorylation [1], it was proposed that
the cellular toxicity of several exogenous/arti¢cial
agents (chemical, or physical like ischemia/reperfu-
sion cycles) known to promote PTP opening in vitro,
might be accounted for by an in situ activation of the
PTP causing ^ among other things ^ an arrest of
aerobic ATP synthesis [50^60] (see also [9] and other
reviews in this issue).
However, as demonstrated by Hunter and Ha-
worth [3^8] (see also Section 6) and several other
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groups, the high-conductance state of the PTP is not
only operated by Ca2, and the toxic e¡ects of a
variety of exogenous compounds are in fact revealing
a few key built-in regulatory mechanisms of the
channel [3^9,24^31,41^49,61^73]. To these built-in
sensors correspond clearly identi¢ed endogenous ef-
fectors, suggesting that beyond its role in accidental/
toxic cell death [50^60], the high-conductance state
of the PTP might be physiologically triggered during
programmed cell death. This view is reinforced by
the observations that (i) the antiapoptotic e¡ects of
the Bcl-2 gene product seem to correlate with its
mitochondrial location [74,75], and that (ii) in vitro,
Bcl-2 seems to inhibit operation of the PTP in its
high-conductance state [21,76,77].
3.1. High-conductance state of the PTP
In its high-conductance state, the PTP was charac-
terized as a channel activated by the cooperative
binding of two Ca2 ions to its matrix domain
[6,8], with a ¢xed molecular cuto¡ of approx. 1500
Da [6], and an electrical conductance of approx. 1.2
nS [9,24]. In this conformation, opening of the PTP
induces in vitro a complete and sustained collapse of
the transmembrane proton gradient, allows the e¥ux
of a variety of other ions (like Ca2) [7] and of small
molecules (like pyrimidylic and adenylic nucleotides)
[3,6], and promotes the di¡usion of components from
the incubation medium into the matrix (like sucrose)
[3^8]. The high-conductance state of the PTP was
found to be highly regulated, and exhibits the fea-
tures of a Ca2-, voltage-, and pH-gated channel [3^
8,44,64,65], modulated by the redox and phosphate
potentials [3^8] (see Fig. 4 and Section 6). Moreover,
opening of the PTP appears to be regulated by direct
binding of a mitochondrial cyclophilin (cyclophilin
D) to its matrix domain, accounting for the inhibi-
tory e¡ect of CsA [62,63,66,68^71]. More recently,
the PTP has been proposed to be also directly regu-
lated by the reactive oxygen species leaking from the
respiratory chain [67], and by the rate of electron
transfer across the respiratory chain complex I [73].
From a structural point of view, the PTP was pro-
posed as soon as 1979 to be formed by the ADP/
ATP translocator [5]. This proposal was made by
Hunter and Haworth when they discovered that the
PTP was regulated by the binding of ADP [5^8], and
that the two inhibitors of the ADP/ATP transloca-
tor, i.e. atractyloside and bongkrekic acid, respec-
tively activated and inhibited the PTP [5]. This
view recently gained further support [31], especially
when it was reported that the translocator reconstit-
uted into liposomes exhibits a channel activity, with
an electrical conductance, a Ca2 sensitivity, and a
voltage dependence that resemble those of the high-
conductance PTP conformation [78]. Still concerning
structural considerations, Haworth and Hunter also
proposed in 1980 that the PTP might participate in
multiprotein complexes bridging the two mitochon-
drial membranes, which they called ‘transient gap
junctions’ [8]. Again, this pioneering view gained
support in electrophysiological studies indicating
that the PTP might be interacting with the outer
membrane porins [46,47], and with the mitochondrial
benzodiazepine receptor [45]. Moreover, isolated mi-
tochondrial contact sites constituted of cyclophilin D
(matrix), ADP/ATP translocator (inner membrane),
creatine kinase (facultative and tissue-dependent, in-
termembrane space), porin (outer membrane), and
hexokinase (facultative and tissue-dependent, extra-
mitochondrial space) exhibit, once integrated into
liposomes, a behavior reminiscent of the high-con-
ductance state of the PTP [79,80].
3.2. PTP and cell death: a mechanism for the release
of proapoptotic factors
As mentioned before, PTP opening in its high-con-
ductance conformation induces unselective solute
£uxes that dissipate the concentration gradients of
relatively big molecules, but since most proteins re-
main trapped in the matrix, the resulting oncotic
imbalance (at least in vitro) causes high amplitude
swelling of the organelle. During swelling, the cristae
Fig. 4. Bioenergetic regulation of the high-conductance state of
the PTP. After [3^8,44,65]. The dashed arrows represent regula-
tive interactions. For explanation see text.
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formed by the inner membrane progressively unfold,
causing eventually a rupture of the outer membrane
that brings into direct communication the former
intermembrane space and the extramitochondrial
medium. Thus, mitochondria with an open high-con-
ductance pore undergo an extensive structural im-
pairment that causes the release in the outer medium
(provided it is saline) of the soluble components nor-
mally trapped in the intermembrane space. Cyto-
chrome c and apoptosis inducing factor (AIF) are
two of these [21^23].
Cytochrome c is a small heme-containing protein
normally adsorbed at the outer aspect of the inner
mitochondrial membrane, which shuttles electrons
between the respiratory chain complexes III and IV
[2]. When released from mitochondria, cytochrome c
induces the activation of caspase 3 which is a key
cytosolic cell death protease [81^83]. AIF is a 50
kDa protein ^ presumably resident of the intermem-
brane space ^ that, once released, can promote direct
activation of caspase 3 and endonucleases [21]. In
summary, the release of cytochrome c and/or AIF
from mitochondria can be identi¢ed with a key event
committing the cell to death. Thus, because of the
outer membrane alterations it induces, PTP opening
in its high-conductance conformation appears as a
good candidate mechanism for the release of apopto-
genic factors from mitochondria [21^23].
Such a mechanism has been proposed to take
place in many forms of apoptosis, suggesting that
the high-conductance state of the PTP could play a
universal role of central executioner of the cell death
program [21]. This generalization was probably ex-
cessive, since in some key cellular models the release
of apoptogenic factors from mitochondria appears to
occur independently of PTP opening [82^85].
However, in some speci¢c cases ^ all concerning
Ca2-dependent cell death ^ the PTP was unambig-
uously shown to play a pivotal role in the sequence
of events committing the cell to death [15^20]. In the
next section, we summarize these models for which a
consensus seems to have been reached.
3.3. PTP and Ca 2+-dependent cell death:
experimental results
A ¢rst indication that PTP opening in its high-
conductance state might act as an apoptotic trigger
came from key studies published by Vayssie're et al.
in 1994 [86], and Petit et al. in 1995 [87], where the
authors showed that early commitment to apoptosis
in di¡erent cell types is associated with both v8
collapse and alterations of the mitochondrial struc-
ture. Concordant observations were then reported in
a study where cells were challenged with proapop-
totic stimuli in vivo, and subsequently sorted accord-
ing to the value of mitochondrial v8 [88]. After a
short-term culture, cells that had retained a high v8
after the proapoptotic treatment did not undergo
apoptosis, while those with a low v8 did. The au-
thors could thus establish a correlation between mi-
tochondrial v8 collapse and early commitment to an
apoptotic fate. At the same time, numerous reports
were suggesting that the early v8 dissipation ob-
served in various types of toxic cell death were de-
pendent on PTP opening [50^60]. Thus, the PTP im-
mediately became the subject of a close scrutiny in
the ¢eld of apoptotic cell death (see other reviews in
this issue).
For the time being, excitotoxic neuronal cell death
observed after sustained glutamate stimulation re-
mains the principal model where several groups
clearly identi¢ed opening of the PTP with an early
causative event in the cell death cascade [15^19]. Glu-
tamate neurotoxicity is triggered by massive Ca2
in£ux arising from overstimulation of the N-meth-
yl-D-aspartate (NMDA) receptors. Such mode of
neuronal cell death is associated with neurodegener-
ative disorders and cerebral ischemia. In 1994,
Thayer and coworkers showed that glutamate-in-
duced Ca2 overloads in neurons are sequestered
by mitochondria, causing ‘uncoupling’ of respiration
and intracellular acidosis, and proposed that mito-
chondria might be responsible for glutamate-induced
cell death [89^91]. At the same time, the group of
Miller observed that neuronal excitotoxic degenera-
tion is initiated at speci¢c sites enriched in mitochon-
dria, and that local Ca2 in£ux in these regions re-
sults in mitochondrial v8 collapse [92]. In 1996 and
1997 the groups of Reynolds [15,19], Montal [16],
Nicotera [17], as well as Nieminen and coworkers
[18] all reported that in response to sustained stim-
ulation of NMDA receptors (i) mitochondria take up
Ca2, (ii) v8 collapses, and (iii) cell death occurs.
Strikingly, CsA was shown to be able to allow com-
plete recovery of v8, and to prevent cell death in all
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of these studies [15^19]. Based on these ¢ndings, a
simple ‘cell death sequence’ was proposed: (i) pro-
longed stimulation of the NMDA receptors of the
neuronal plasma membrane causes a sustained in£ux
of Ca2 from the extracellular medium; (ii) mito-
chondria take up the Ca2 entering the cell ; (iii)
opening of the PTP in its high-conductance state is
triggered; (iv) mitochondrial v8 collapses; and (v)
cell death occurs. Since the morphological features of
excitotoxic cell death associate necrotic and apop-
totic signs, it seems likely that PTP opening results
in cell death because it causes both (i) an arrest of
aerobic ATP synthesis ^ promoting necrotic signs
[93] ; and (ii) mitochondrial swelling, outer mem-
brane rupture, and release of proapoptotic factors ^
promoting apoptotic signs [93] (for a recent review
see [94]).
Another model of Ca2-dependent cell death
where the PTP might play a role corresponds to
the induction of apoptosis by thapsigargin [20,95]
(a model introduced by the group of Distelhorst
[96^100]). Thapsigargin inhibits the ER Ca2-AT-
Pase, blocking the uptake leg of the ER Ca2 cycle.
As a result, the ER Ca2 stores become progressively
and irreversibly emptied, causing in turn opening of
the store-operated Ca2 entry channels in the plasma
membrane, and massive in£ow of Ca2 from the ex-
tracellular medium. Under such conditions (i) mito-
chondria take up Ca2 [97,101]; (ii) mitochondrial
v8 collapses [20]; and (iii) apoptosis occurs [20,95^
100]. In general mechanistic terms, this situation is
very reminiscent of excitotoxic neuronal cell death.
Strikingly, here also CsA was reported to be e⁄cient
at preventing both mitochondrial v8 decrease [20],
and signs of apoptosis [20,95]. It should be noted,
however, that there is a controversy on whether the
capacitative Ca2 in£ux taking place after thapsigar-
gin treatment is or is not necessary for apoptosis to
occur [102,103]. Since operation of the PTP in its
high-conductance state is di⁄cult to conceive in the
absence of mitochondrial Ca2 uptake caused by a
sustained store-operated Ca2 entry [101], further
studies will be needed to clarify the latter point.
Ca2-dependent mechanisms involving the PTP
might also be responsible for the cases of apoptosis
observed (i) after interleukin withdrawal from inter-
leukin-dependent cell lines [104], and (ii) in L-amy-
loid neurotoxicity [105]. Indeed, (i) in the case of
interleukin withdrawal, progressive emptying of the
ER Ca2 pool concomitant with mitochondrial Ca2
uptake was reported to be correlated with the onset
of apoptosis [104]; and (ii) in the case of L-amyloid
neurotoxicity, neuronal cell death was shown to be
associated with mitochondrial v8 collapse, while
both v8 collapse and cell death could be inhibited
by Ca2 bu¡ers and antioxidants [105]. Thus, it
should be interesting to test the e¡ects of CsA in
these models.
Strikingly, in all four cases of Ca2-dependent cell
death cited above, Bcl-2 was found to be an e⁄cient
blocker of the apoptotic program [96^100,103^107].
However, in spite of the prominent mitochondrial
localization of Bcl-2 [74,75], and of possible direct
inhibitory e¡ects of Bcl-2 on the PTP [21,76,77], dur-
ing Ca2-dependent apoptosis, Bcl-2 seems to act on
other targets and/or stages of the cell death pathway.
In the case of glutamate neurotoxicity, the protective
action of Bcl-2 seems to take place far downstream
from PTP operation (compare the time courses of
PTP operation in [15^19], and of Bcl-2 protection
in [107]). On the contrary, in thapsigargin-induced
cell death [96^100], or during apoptosis caused by
interleukin withdrawal [104], Bcl-2 seems to act up-
stream from PTP operation by preventing the initial
(non-mitochondrial) steps of Ca2 mobilization. Fi-
nally, in L-amyloid neurotoxicity, Bcl-2 might act
upstream from and/or directly at the mitochondrial
level [105]. These examples demonstrate that the Bcl-
2 sensitivity of a process is not a proof of PTP in-
volvement, and that CsA remains the main available
tool to test the PTP dependence of a sequence of
events.
3.4. Summary
Opening of the PTP in its high conductance state
causes irreversible dissipation of v8, colloidosmotic
swelling of the matrix, rupture of the outer mito-
chondrial membrane, and release of proapoptotic
factors from the intermembrane space. Even this ‘le-
thal’ conformation of the channel is endowed with
several built-in control points of regulation, suggest-
ing a participation in the physiological pathways to
programmed cell death. Persistent v8 collapse com-
patible with PTP opening in its high-conductance
state has consistently been observed during Ca2-de-
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pendent cell death. Moreover, both mitochondrial
depolarization and progression into the apoptotic
program can be prevented by CsA that blocks the
PTP. In these apoptotic models, PTP opening ap-
pears to depend on an initial phase of mitochondrial
Ca2 uptake.
4. Two conformations for the PTP: switching from
low- to high-conductance state
Based on the observations summarized in the two
last sections, it appears that either during normal
Ca2 signaling events, or during Ca2-dependent
cell death, a similar process is responsible for trigger-
ing PTP opening: Ca2 uptake by mitochondria.
How then to explain that di¡erent open conforma-
tions of the pore can arise from a similar type of
trigger signal? In other words, what are the factors
that divert the PTP from its Ca2 release channel
function (low-conductance state) to transform it
into a cell death-promoting channel (high-conduct-
ance state)?
4.1. Conductance switch: pH versus Ca 2+
Fig. 5 shows isolated mitochondria challenged
with Ca2 undergoing the transient membrane per-
meability change that we termed mitochondrial
CICR [13,14]. As shown previously, mitochondrial
CICR takes the form of a Ca2 transient detectable
in the extramitochondrial medium due to transitory
PTP opening [13,14] (Fig. 5A). This process is not
accompanied by swelling and, instead, mitochondria
undergo a phase of shrinkage (Fig. 5A,B). This
shrinkage is due the net solute loss associated with
K release through the PTP [14], while mitochondria
remain impermeable to sucrose. Thus, the PTP
adopts here a low-conductance conformation selec-
tive for small ions (see Section 2). This is con¢rmed
by the experiments of Fig. 5B, where mitochondria
were submitted to osmotic pressure steps by adding
sucrose at di¡erent stages of the CICR spike. The
rate of mitochondrial shrinkage observed after su-
crose addition is independent of the stage at which
the osmotic pressure is raised (Fig. 5B), con¢rming
that mitochondria operate the PTP in low-conduct-
ance state during mitochondrial CICR [7,14].
Strikingly, if the size of the Ca2 load is increased,
the response no longer takes the appearance of a
spike, but rather exhibits a CsA-sensitive triphasic
pattern (Fig. 6A). The initial phase of the response
is similar to a CICR spike, but before Ca2 re-up-
take is completed, a new cycle of Ca2 release takes
place. The latter, however, is irreversible and associ-
ated with large amplitude swelling of mitochondria
(Fig. 6A). Comparative analysis of K £uxes and
volume changes rules out the possibility that the
PTP sequentially opens under di¡erent conforma-
tions in di¡erent mitochondrial subpopulations. In-
deed, (i) during the initial phase of the response,
mitochondria remain impermeable to sucrose (Fig.
6B), while all of their K contents is released (Fig.
6A); and (ii) during the subsequent phase of irrever-
Fig. 5. Opening of the PTP under its low-conductance state
during mitochondrial CICR in vitro. See also [13,14,32^35]. Rat
liver mitochondria were isolated, suspended in a hypotonic me-
dium, and stimulated with Ca2 (40 nmol mg31) as in [13]. (A)
Typical mitochondrial CICR response. The simultaneous
changes in extramitochondrial Ca2, mitochondrial volume, and
extramitochondrial potassium were monitored as in [14]. Note
the mitochondrial contraction concomitant with potassium ef-
£ux. (B) Osmometric demonstration of the low-conductance
(sucrose-impermeable) conformation of the PTP during mito-
chondrial CICR. For explanation see text and [14].
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sible Ca2 release, mitochondria become permeable
to sucrose (Fig. 6B), while no further K release is
observed (Fig. 6A). Thus, the triphasic pattern ob-
served after increased Ca2 loads corresponds to a
sequential switch between the two conductance states
of the PTP.
As mentioned before (see Section 2), operation of
the low-conductance state of the PTP is related to
Ca2 only indirectly, and is in fact triggered by the
changes in matrix pH that accompany mitochondrial
Ca2 uptake. In Fig. 7A we reproduced the condi-
tions of Fig. 6, except that we loaded mitochondria
with Sr2 instead of Ca2. The former cation is
transported by the mitochondrial uniporter in a
way similar to Ca2, and thus induces matrix pH
changes similar to those observed when Ca2 is
used as stimulus [27]. However, Sr2 is unable to
act as an agonist at the level of the Ca2 sensor of
the PTP [3^8], and thus cannot trigger channel open-
ing by binding to this site. Fig. 7A shows that load-
ing mitochondria with Sr2 leads to pH-dependent
PTP opening (see the inhibiting e¡ect of acetate) in
its low-conductance mode, but prevents subsequent
switch to the high-conductance state. This result
demonstrates that the low-conductance state is not
under the direct dependence of the Ca2 sensor of
the channel, and that, instead, switching to the high-
conductance state requires the saturation of the in-
ternal binding sites of the channel by Ca2. This
result is con¢rmed in Fig. 7B. In this experiment,
we reproduced the protocol of Fig. 6 using Ca2,
but this time in the presence of the K-H exchanger
nigericin. This ionophore electroneutrally equili-
brates the transmembrane gradients of H and K
and thus converts mitochondrial vpH into a vpK.
Thus, in the presence of nigericin mitochondria be-
have ‘as if’ the respiratory chain was pumping K
Fig. 6. Conformational switch of the PTP in vitro. The condi-
tions are identical to those used in Fig. 5, excepted that the
amount of Ca2 used to trigger the response has been multi-
plied by 3 (120 nmol mg31). (A) Biphasic patterns of Ca2 re-
lease and volume changes, concomitant with a monophasic re-
lease of potassium. The light traces were observed in the
presence of 10 WM CsA, added either before stimulation, or im-
mediately before the second phase (asterisk). (B) Osmometric
demonstration of the change in sucrose permeability occurring
between the two release phases, evidencing a switch from low-
to high-conductance (sucrose-permeable) state.
Fig. 7. The low-conductance state of the PTP is operated by
matrix pH, while switching to the high-conductance state is
Ca2-dependent. See also [13,14,35]. The conditions are similar
to those of Fig. 6, except that Ca2 was replaced by Sr2 in A,
and that the experiment was performed in the presence of 2 WM
nigericin in B. In A, the ‘Sr2+Acet.’ trace was recorded in the
presence of 1 mM acetate, which electroneutrally di¡uses across
the inner mitochondrial membrane and bu¡ers matrix pH
changes. For detailed explanation see text.
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instead of protons. As a result, matrix pH is clamped
to low values. Fig. 7B shows that after Ca2 loading,
operation of the PTP in its low-conductance state is
totally prevented by nigericin. However, opening of
the PTP in its high-conductance state is still observed
after a lag time, at a distance from the Ca2 stimulus
(Fig. 7B).
4.2. Conductance switch: fast versus slow Ca 2+
loading
These experiments show that conversion between
the two open conformations of the PTP can be ob-
served in vitro by an increased mitochondrial Ca2
load su⁄cient to saturate the Ca2-binding sites of
the channel, and to override the control exerted by
pH on the pore. As noted before (see Section 2), the
changes in matrix pH consecutive to mitochondrial
Ca2 uptake that are responsible for triggering PTP
opening in its low-conductance state result from the
activity of the respiratory chain [14,35]. The respira-
tory chain is a complex set of proton pumps that
continuously expel protons from the matrix, and
whose function is regulated by the value of the trans-
membrane proton electrochemical gradient, i.e. the
sum of v8 and vpH (expressed in electrical terms)
[1,2]. For the non-specialist reader, we can compare
what the respiratory chain does with protons in mi-
tochondria, to what a voltage-clamp device does with
electrons in electrophysiological studies. When the
mitochondrial membrane becomes depolarized, e.g.,
when Ca2 (positive charges) enters the matrix, the
respiratory chain ‘senses’ the v8 drop, and immedi-
ately increases its proton extrusion rate until the
original ‘resting’ v8 (plus vpH) value is restored.
This roughly corresponds to a voltage-clamp activity.
However, at major variance from arti¢cial voltage-
clamp devices, the respiratory chain pumps out pro-
tons, and thus the voltage corrections performed are
accompanied by changes in matrix pH. These
changes in matrix pH, however, are bu¡ered in
time by the electroneutral redistribution of a variety
of permeant weak acids, such as, for instance, phos-
phate or oxidizable substrates [14,35] (Fig. 8). Thus,
when the rate of Ca2 in£ux causing a v8 drop is
faster than the rate of electroneutral redistribution of
weak acids, voltage correction by the respiratory
chain is accompanied by a pronounced matrix alka-
linization. On the contrary, if a similar amount of
Ca2 is accumulated, but this time at a slow rate,
the redistribution of weak acid can keep pace, and
voltage correction by the respiratory chain is no lon-
ger accompanied by signi¢cant increases in matrix
pH [14,35] (Fig. 8). Thus, a fast rate of Ca2 delivery
can trigger PTP opening under its low-conductance,
pH-dependent conformation, while a slow rate pre-
vents pH-dependent channel opening, and results in
progressive mitochondrial Ca2 overloading (Figs. 8
and 9). In the latter case, the Ca2 sensor of the PTP
becomes progressively saturated, and the channel
Fig. 8. pH-dependent operation of the PTP is sensitive to the
rate of mitochondrial Ca2 uptake. After [13,14,35]. The condi-
tions are similar to those of Fig. 1 [14]. The simultaneous
changes in extramitochondrial Ca2 and matrix pH were moni-
tored as in [14]. (A) Slow Ca2 stimulation of mitochondria
with three Ca2 additions (3U10 nmol mg31). (B) Rapid stimu-
lation with three Ca2 additions using the same amount of
Ca2 as in A. AH, permeant weak acids di¡using electroneu-
trally down the vpH. In the cartoons, the thickness of the ar-
rows schematically re£ects the rates of transport. For explana-
tion see text.
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eventually opens in its high-conductance conforma-
tion (Fig. 9). Thus, both conformations of the PTP
are triggered by Ca2, but by di¡erent mechanisms,
and it is mainly the rate of the extramitochondrial
[Ca2] rise and the rate of mitochondrial Ca2 up-
take that determine whether the PTP will open in a
low-conductance state after limited Ca2 loading
(fast rates), or in a high-conductance state after mas-
sive Ca2 overloading (slow rates).
4.3. Summary
The PTP can switch from low- to high-conduct-
ance state. While the low-conductance conformation
is mainly pH-operated, the conformational switch
appears to be strictly dependent on the saturation
of the internal Ca2 binding of the channel. Fast
mitochondrial Ca2 uptake promotes signi¢cant
changes in matrix pH for modest Ca2 loads, and
results in operation of the PTP in its low-conduc-
tance, pH-dependent conformation. Slow mitochon-
drial Ca2 uptake results in massive Ca2 overload-
ing without signi¢cant changes in matrix pH, and
eventually causes opening of the PTP in its high-con-
ductance, Ca2-dependent conformation.
5. From Ca2+ signaling to Ca2+-dependent cell death:
a biophysical model
The latter observations demonstrate that operation
of either pore conformation simply depends on the
rate of the extramitochondrial [Ca2] increases, and
on the rate of mitochondrial Ca2 uptake. We show
below that the tight dependence of the PTP open
conformational state on such kinetic parameters pro-
vides a simple reading frame to predict the outcome
(survival or death) of the Ca2 signals in living cells.
This leads us to propose a model of cell death where
the trigger apoptotic signal is simply encoded in the
shape and the origin of the cytosolic Ca2 signals.
5.1. Shape of Ca 2+ signals and rate of mitochondrial
Ca 2+uptake : fromsignalingtocelldeath
During physiological signaling events triggered by
Ca2 mobilizing hormones, the cytosolic Ca2 sig-
nals are organized in time as single or repetitive
spikes of variable frequency, and in space as propa-
gating wavefronts [108^113]. In non-excitable cells,
these elementary spikes result in ¢rst instance from
the coordinated operation of Ca2 release from the
ER, Ca2 extrusion by the plasma membrane Ca2-
ATPases, Ca2 entry through the store-operated
Ca2 channels, and Ca2 re-uptake by the ER
Ca2-ATPases (reviewed in [114]). In this context,
the mitochondria located near the IP3-dependent
Ca2 release channels of the ER periodically sense
intense and short-lived Ca2 transients [37]. During
the generation of such localized Ca2 hot spots, the
neighboring mitochondria take up Ca2 at an ex-
tremely fast rate, due to the high local Ca2 concen-
tration that activates the mitochondrial Ca2 uni-
porter [37] (see also Section 2). Since the rate of
mitochondrial Ca2 uptake is probably su⁄cient to
transiently override matrix pH bu¡ering, the PTP
opens in its low-conductance conformation, and mi-
tochondrial CICR occurs, contributing to the ampli-
¢cation of the mean cytosolic Ca2 spike [13,14].
Note that in this case, no mitochondrial Ca2 over-
loading occurs since PTP opening is triggered after a
very moderate ^ but fast ^ transient increase in mi-
tochondrial Ca2 [14]. As a result, mitochondria par-
ticipate in Ca2 signaling, do not swell, and maintain
their normal functions (Fig. 10A).
Fig. 9. The rate of mitochondrial Ca2 uptake determines the
mode of PTP operation. The conditions are similar to those of
Fig. 8. The simultaneous changes in extramitochondrial Ca2
and mitochondrial volume were monitored as in [14], but the
light scattering signal was not calibrated. (A) Rapid Ca2 stim-
ulation as in Fig. 8; low-conductance PTP opening is observed
(shrinkage). (B) Slow Ca2 stimulation using pulses of individu-
al height as in A, and continued until Ca2 release occurred;
high-conductance PTP opening is observed (swelling). For ex-
planation see text.
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Let us now consider the case of Ca2 signals such
as those observed after thapsigargin challenge. As
noted before, thapsigargin irreversibly empties the
ER Ca2 pool, and the monotonic persistent cyto-
solic Ca2 elevation observed in treated cells results
from the establishment of a steady state between
Ca2 entry through the store-operated channels of
the plasma membrane, Ca2 extrusion by the plasma
membrane Ca2-ATPases, and Ca2 uptake by mi-
tochondria [101]. In this case, the localized Ca2 hot
spots cited above are not generated, and mitochon-
dria face a steady submicromolar plateau of cytosolic
Ca2 concentration. Under these conditions, RaM-
mediated Ca2 uptake spontaneously inactivates
after a few milliseconds [36,101], and the mitochon-
drial Ca2 uniporter remains the sole operating up-
take pathway. At those submicromolar cytosolic
Ca2 concentrations, uniporter-mediated Ca2 up-
take is slow [27], and mitochondria get progressively
overloaded with Ca2 at an extremely slow rate
[101]. The massive mitochondrial Ca2 overloading
observed under these conditions indicates that the
Fig. 10. Model of the transition between Ca2 signaling and Ca2-dependent apoptosis. The model elements are schematized as in
Fig. 3. (A) Normal Ca2 signaling as in Fig. 3; the PTP is transiently operated (phase 2) in its low-conductance, pH-dependent con-
formation. (B) Pathological Ca2 signaling, like in thapsigargin-treated cells ; mitochondrial Ca2 overloading leads to PTP opening in
its high-conductance, Ca2-dependent conformation (phase 3); as a result, mitochondria swell and the outer membrane is disrupted.
For explanation see text.
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PTP remains closed for long periods. This result
is expected since slow mitochondrial Ca2 uptake
probably occurs without signi¢cant change in matrix
pH as observed in vitro, thus precluding operation
of the PTP under its pH-dependent conformation,
i.e., preventing mitochondrial CICR from taking
place. As the Ca2 load further increases, however,
the PTP eventually opens in its high-conductance
state, causing irreversible mitochondrial depolar-
ization, and committing the cell to death [20] (Fig.
10B).
A very similar scenario can be proposed for exci-
totoxic neuronal cell death [15^19]. In neurons over-
stimulated with glutamate or its agonists, a steady-
state increase in cytosolic Ca2 takes place that re-
sults from the concerted operation of Ca2 in£ux
through the NMDA channels of the plasma mem-
brane, Ca2 extrusion by the plasma membrane
Ca2-ATPases, and Ca2 uptake by mitochondria
[89^92] (for a recent review see [94]). Since the cyto-
solic Ca2 concentration is maintained at near micro-
molar steady values, Ca2 in£ux through the Ca2
uniporter is ^ here also ^ slow due to the low extra-
mitochondrial Ca2 concentration. As a result, (i)
pH-dependent PTP opening is prevented, (ii) mito-
chondria become progressively overloaded with
Ca2, and (iii) the PTP eventually opens in its
high-conductance state, committing the neuron to
death [15^19].
5.2. General conclusion
Our results indicate that switching from the low-
conductance state of the PTP to the high-conduc-
tance open conformation is an irreversible process
that is strictly dependent on the saturation of the
internal Ca2-binding sites of the channel. Thus,
the high-conductance state of the PTP, which was
shown to play a pivotal role in the course of excito-
toxic and thapsigargin-induced cell death, might re-
sult from a Ca2-dependent conformational shift of
the low-conductance state, normally participating in
the regulation of cellular Ca2 homeostasis as a pH-
operated channel. These observations have led us to
propose a simple biophysical model of the transition
between Ca2 signaling and Ca2-dependent apopto-
sis, where, depending on the shape of the cytosolic
Ca2 signals, the di¡erences in the kinetics of mito-
chondrial Ca2 uptake determine the type of PTP
conformation operated (Fig. 10).
6. Tribute to Hunter and Haworth
By 1980, Hunter and Haworth had already discov-
ered and characterized many of the key features of
the PTP [3^8]. However, few people were ready to
believe in the existence of mitochondrial channels at
this time. As a result, their studies went unheeded for
10 years (for notable exceptions, see [29,30,61]), and
when new groups ¢nally decided to develop their
work, Hunter had left research, and Haworth had
changed his ¢eld of investigation. In this annex, we
summarize the striking contribution of these two au-
thors, with the hope that the reader will feel stimu-
lated to read the ¢ve key papers (plus one abstract)
that pioneered the ¢eld [3^8].
While the process of Ca2-induced mitochondrial
swelling, referred to as ‘mitochondrial damage’, or
‘mitochondrial aging’, had been known for years,
Hunter and Haworth were the ¢rst to clearly show
that the progressive global swelling, loss of respira-
tory control, and Ca2 release observed in mitochon-
drial suspensions after Ca2 addition were in fact
due to an ‘all-or-nothing’ abrupt increase in the per-
meability of the mitochondrial membrane occurring
at the level of individual mitochondria, and progres-
sively recruiting increasing fractions of the mitochon-
drial population [3^8]. They thus introduced the con-
cept of a variable threshold for activation of the
process of permeability transition in di¡erent individ-
ual mitochondria, and applied electron microscopy,
respiratory control assays, calcium release assays,
and light scattering methods to the quantitative de-
termination of the fraction of mitochondria with an
open pore within a whole mitochondrial population
[3^8]. In 1976, they showed that the PTP was unse-
lectively permeable to H, Ca2, Mg2, choline, glu-
cose, sucrose, and NAD(P)H [3,6]. Using dextrans of
di¡erent molecular weight, they determined the mo-
lecular mass cuto¡ of the PTP (6 1500 Da) [6]. They
also showed that PTP opening is a reversible process,
since mitochondria with an open pore could be com-
pletely resealed by simply adding ATP plus Mg2, or
by chelating Ca2 with EGTA [3,6].
They showed that the PTP is a channel activated
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by the allosteric binding of two Ca ions at the matrix
side of the channel [3,6,8], and that ADP and Mg2
act as competitive inhibitors [5,7,8]. They found that
the two redox couples NAD(P)/NAD(P)H were
also regulating the pore, due to a direct interaction
of the nucleotides with the channel [3^5,8]. They
showed that pH was modulating the PTP [6], and
recognized that energization per se, independently
of its origin ^ substrate oxidation by the respiratory
chain [7], or ATP hydrolysis by the mitochondrial
ATPase [5] ^ was a pore modulator, since in both
cases FCCP was causing PTP opening [5,7].
They showed that phosphate and fatty acids were
pore inducers [3], and that Sr2 was an inhibitor of
the PTP acting at the level of the internal Ca2-bind-
ing sites of the channel [3^8]. They characterized the
inhibiting e¡ects of N-ethylmaleimide (NEM) and
the activating e¡ects of arsenate [3], and showed
that atractyloside and bongkrekic acid were respec-
tively activating and inhibiting the PTP [5].
Based on the e¡ects of ADP [3^8], atractyloside
[5], and bongkrekic acid [5], they proposed that the
ATP/ADP translocator might be part of the PTP [5].
Strikingly, they also made the hypothesis that the
PTP might participate in mitochondrial contact sites:
‘the channel which is most similar to the inner mem-
brane channel, in being both nonspeci¢c and chemi-
cally gated, is perhaps the channel which spans the
intercellular gap junction ... It is tempting to specu-
late that opening of the inner membrane channel
could entail fusion with the outer membrane, pro-
ducing a transient gap junction’ [8].
Haworth and Hunter discovered PTP £ickering in
1979: ‘the Ca2-induced permeability is discontinu-
ous in time: the treated mitochondria must be con-
tinuously switching between a permeable state and
an impermeable state’ [6]. Finally, they also detected
and analyzed the subconductance state of the PTP [7]
as they found that mitochondria impermeable to su-
crose could still release Ca2 at a fast rate, in a
ruthenium red-insensitive manner, and in the absence
of added Na : ‘Do the mitochondria which remain
in the aggregated con¢guration release Ca2 by a
mechanism totally unrelated to the transition, or is
the release still transitional (in the sense of having a
lag period followed by a sudden release) without
change in permeability to sucrose? This remains an
open question. Some involvement of the transition
mechanism is suggested by the observation that the
release at low levels of Ca2 is still insensitive to
ruthenium red’ [7].
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